Loxapine

Loxitane

10MG BASE, 25MG BASE, 50MG BASE tabletVereinigte StaatenNicht im HandelZugelassen am 25. Feb. 1975

In anderen Ländern

Dieselben Wirkstoffe in anderen Registern, dieselbe Marke zuerst.

XylacKanada · 2.5 MG · Tablet · Pendopharm Division of Pharmascience INCGleiche Darreichungsform
XylacKanada · 25 MG · Tablet · Pendopharm Division of Pharmascience INCGleiche Darreichungsform
XylacKanada · 10 MG · Tablet · Pendopharm Division of Pharmascience INCGleiche Darreichungsform
Adasuve 9,1 MG Polvo Para Inhalacion (Unidosis)Spanien · 9,1 mg · polvo para inhalación (unidosis) · Ferrer Internacional S.A. · Im HandelGleicher Wirkstoff
Adasuve 9,1 MG Polvo Para Inhalacion (Unidosis)Spanien · 9,1 mg · polvo para inhalación (unidosis) · Ferrer Internacional S.A. · ZugelassenGleicher Wirkstoff
AdasuveEuropäische Union · Ferrer Internacional S.A.Gleicher Wirkstoff

Packung	Code	Status
LOXAPINE SUCCINATE EQ 10MG BASE Federal Register determination that product was discontinued or withdrawn for s or e reasons	NDA017525-006	Discontinued
LOXAPINE SUCCINATE EQ 25MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NDA017525-007	Discontinued
LOXAPINE SUCCINATE EQ 50MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NDA017525-008	Discontinued